The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Atyr Pharma Inc’s stock clocked out at $2.90, down -8.93% from its previous closing price of $3.19. In other words, the price has decreased by -$8.93 from its previous closing price. On the day, 1.39 million shares were traded. ATYR stock price reached its highest trading level at $3.15 during the session, while it also had its lowest trading level at $2.81.
Ratios:
To gain a deeper understanding of ATYR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.41 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on October 04, 2024, initiated with a Overweight rating and assigned the stock a target price of $17.
On September 05, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $9.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 24 ’24 when SCHIMMEL PAUL bought 52,300 shares for $1.93 per share. The transaction valued at 101,038 led to the insider holds 413,023 shares of the business.
SCHIMMEL PAUL bought 41,052 shares of ATYR for $71,500 on Jul 22 ’24. The Director now owns 354,075 shares after completing the transaction at $1.74 per share. On Jul 23 ’24, another insider, SCHIMMEL PAUL, who serves as the Director of the company, bought 6,648 shares for $1.82 each. As a result, the insider paid 12,075 and bolstered with 360,723 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATYR now has a Market Capitalization of 243852672 and an Enterprise Value of 191249696. For the stock, the TTM Price-to-Sale (P/S) ratio is 965.50 while its Price-to-Book (P/B) ratio in mrq is 3.37. Its current Enterprise Value per Revenue stands at 813.828 whereas that against EBITDA is -2.84.
Stock Price History:
Over the past 52 weeks, ATYR has reached a high of $3.80, while it has fallen to a 52-week low of $1.09. The 50-Day Moving Average of the stock is 16.74%, while the 200-Day Moving Average is calculated to be 47.60%.
Shares Statistics:
It appears that ATYR traded 792.04K shares on average per day over the past three months and 829850 shares per day over the past ten days. A total of 83.94M shares are outstanding, with a floating share count of 81.75M. Insiders hold about 2.61% of the company’s shares, while institutions hold 63.05% stake in the company. Shares short for ATYR as of 1730332800 were 1662000 with a Short Ratio of 2.10, compared to 1727654400 on 1364879. Therefore, it implies a Short% of Shares Outstanding of 1662000 and a Short% of Float of 2.9899999999999998.
